| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.05 |